AMENDED AND RESTATED COLLABORATION AGREEMENTCollaboration Agreement • June 30th, 2011 • Sunesis Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledJune 30th, 2011 Company IndustryThis COLLABORATION AGREEMENT (this “Agreement”), effective as of March 31, 2011 (the “Effective Date”), is made by and between Sunesis Pharmaceuticals, Inc., a Delaware corporation, having a principal place of business at 341 Oyster Point Boulevard, South San Francisco, CA 94080 (“Sunesis”), and Biogen Idec MA Inc., a Massachusetts corporation, having a principal place of business at 14 Cambridge Center, Cambridge, MA (“Biogen Idec”). Sunesis and Biogen Idec are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
AMENDED AND RESTATED COLLABORATION AGREEMENTCollaboration Agreement • May 12th, 2011 • Sunesis Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledMay 12th, 2011 Company IndustryThis COLLABORATION AGREEMENT (this “Agreement”), effective as of March 31, 2011 (the “Effective Date”), is made by and between Sunesis Pharmaceuticals, Inc., a Delaware corporation, having a principal place of business at 341 Oyster Point Boulevard, South San Francisco, CA 94080 (“Sunesis”), and Biogen Idec MA Inc., a Massachusetts corporation, having a principal place of business at 14 Cambridge Center, Cambridge, MA (“Biogen Idec”). Sunesis and Biogen Idec are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.